Skip to main content

Please wait ...

Rick Doblin, PhD


Rick Doblin, PhD, Executive Director, Multidisciplinary Association for Psychedelic Studies (MAPS); chair of the board of directors MAPS Public Benefit Corporation.

 

Speaker Disclosures:
Financial: Richard Doblin has an employment relationship with Multidisciplinary Association for Psychedelic Studies, Inc. He receives a speaking honorarium and recording royalties from PESI, Inc. He has no relevant financial relationships with ineligible organizations.
Non-financial: Richard Doblin has no relevant non-financial relationships.

The Use of Mind-Altering Substances: MDMA, Psilocybin, and Marijuana for Treating PTSD and other Mental Distress


Faculty:
Michael Mithoefer, MD |  Rick Doblin, PhD |  Phil Wolfson, MD |  Sue Carter, PhD |  Robin Carhart-Harris, PhD |  Andrew Penn, RN, MS, NP, CNS, APRN-BC |  Richard C. Schwartz, PhD |  Anne Wagner, PhD, C Psych |  ....
Duration:
3 Hours 59 Minutes
Copyright:
May 18, 2021
Product Code:
POS052719
Media Type:
Digital Seminar
Price:
$89.99 - 2023 June Super Sale Standard - $179.99

Showing 1 to 2 of 2 entries